DOCSLIB.ORG

K162950 Trade/D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
K162950 Trade/D DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service ____________________________________________________________________________________________________________________________ Food and Drug Administration 10903 New Hampshire Avenue Document Control Center – WO66-G609 Silver Spring, MD 20993-0002 BIOMERIEUX, INC. NATHAN HARDESTY MANAGER, REGULATORY AFFAIRS MICROBIOLOGY 595 ANGLUM RD. HAZELWOOD MO 63042 Re: K162950 Trade/Device Name: VITEK MS Regulation Number: 21 CFR 866.3361 Regulation Name: Mass spectrometer system for clinical use for the identification of microorganisms Regulatory Class: II Product Code: PEX Dated: June 16, 2017 Received: June 19, 2017 Dear Mr. Hardesty: This letter corrects our substantially equivalent letter of July 22, 2017. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA’s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements Page 2—Mr. Hardesty as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- 1050. If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH’s Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Uwe Scherf, M.Sc., Ph.D. Director Division of Microbiology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health Enclosure Section 1.5 (Continued) Indications for Use Attachment Abiotrophia defectiva Candida parapsilosis 1 Achromobacter denitrificans Candida pelliculosa 1 Achromobacter xylosoxidans Candida rugosa Acinetobacter baumannii complex Candida tropicalis Acinetobacter haemolyticus Candida utilis Acinetobacter junii Candida zeylanoides Acinetobacter lwoffii Chryseobacterium indologenes Actinomyces meyeri Citrobacter amalonaticus 5 Actinomyces neuii Citrobacter braaki 5 Actinomyces odontolyticus Citrobacter freundii Aerococcus viridans Citrobacter koseri 2 5 Aeromonas hydrophila/caviae Citrobacter youngae 2 3 Aeromonas sobria Clostridium clostridioforme Aggregatibacter actinomycetemcomitans Clostridium difficile Aggregatibacter aphrophilus Clostridium perfringens Aggregatibacter segnis Clostridium ramosum Alcaligenes faecalis ssp faecalis Corynebacterium jeikeium Bacteroides caccae Cronobacter sakazakii Bacteroides fragilis Cryptococcus neoformans Bacteroides ovatus 4 Edwardsiella hoshinae Bacteroides thetaiotaomicron Edwardsiella tarda Bacteroides uniformis Eikenella corrodens Bacteroides vulgatus Elizabethkingia meningoseptica Bordetella parapertussis Enterobacter aerogenes 6 Bordetella pertussis Enterobacter asburiae Brevundimonas diminuta Enterobacter cancerogenus 6 Burkholderia multivorans Enterobacter cloacae Campylobacter coli Enterococcus avium Campylobacter jejuni Enterococcus casseliflavus Candida albicans Enterococcus durans Candida dubliniensis Enterococcus faecalis Candida famata Enterococcus faecium Candida glabrata Enterococcus gallinarum 7 Candida guilliermondii Escherichia coli Candida haemulonii Escherichia fergusonii Candida inconspicua Escherichia hermannii Candida intermedia Ewingella americana Candida kefyr Finegoldia magna Candida krusei Fusobacterium necrophorum Candida lambica Fusobacterium nucleatum Candida lipolytica Gardnerella vaginalis Candida lusitaniae Gemella haemolysans Candida norvegensis Gemella morbillorum Granulicatella adiacens Proteus mirabilis 11 Haemophilus influenzae Proteus penneri 11 Haemophilus parahaemolyticus Proteus vulgaris Haemophilus parainfluenzae Providencia rettgeri Hafnia alvei Providencia stuartii Kingella denitrificans Pseudomonas aeruginosa Kingella kingae Pseudomonas fluorescens Klebsiella oxytoca Pseudomonas putida Klebsiella pneumoniae Pseudomonas stutzeri Kodamaea ohmeri Ralstonia pickettii Lactococcus garvieae Raoultella ornithinolytica Lactococcus lactis ssp lactis 8 Raoultella planticola Leclercia adecarboxylata Rhizobium radiobacter Legionella pneumophila Rhodotorula mucilaginosa Leuconostoc mesenteroides Rothia mucilaginosa Leuconostoc pseudomesenteroides Saccharomyces cerevisiae 9 Listeria monocytogenes Salmonella group Malassezia furfur Saprochaete capitata Malassezia pachydermatis Serratia fonticola Micrococcus luteus Serratia liquefaciens Mobiluncus curtisii Serratia marcescens Moraxella (Branhamella) catarrhalis Serratia odorifera Morganella morganii Sphingobacterium multivorum Neisseria cinerea Sphingobacterium spiritivorum 9 Neisseria gonorrhoeae Sphingomonas paucimobilis Neisseria meningitidis Staphylococcus aureus Neisseria mucosa 10 Staphylococcus capitis Ochrobactrum anthropi Staphylococcus cohnii ssp cohnii Oligella ureolytica Staphylococcus cohnii ssp urealyticus Oligella urethralis Staphylococcus epidermidis Pantoea agglomerans Staphylococcus haemolyticus Parvimonas micra Staphylococcus hominis ssp hominis 12 Pasteurella multocida Staphylococcus lugdunensis Pediococcus acidilactici Staphylococcus saprophyticus Peptoniphilus asaccharolyticus Staphylococcus schleiferi Peptostreptococcus anaerobius Staphylococcus sciuri Pluralibacter gergoviae Staphylococcus simulans Prevotella bivia Staphylococcus warneri Prevotella buccae Stenotrophomonas maltophilia Prevotella denticola Streptococcus agalactiae Prevotella intermedia Streptococcus anginosus Prevotella melaninogenica Streptococcus constellatus Propionibacterium acnes Streptococcus dysgalactiae Streptococcus gallolyticus ssp gallolyticus Streptococcus infantarius ssp coli Mycobacterium tuberculosis complex: 16 Streptococcus infantarius ssp infantarius Mycobacterium africanum Streptococcus intermedius Mycobacterium bovis Streptococcus mitis/Streptococcus oralis Mycobacterium canettii Streptococcus mutans Mycobacterium microti Streptococcus pneumoniae Mycobacterium pinnipedii Streptococcus pyogenes Mycobacterium tuberculosis Streptococcus salivarius ssp salivarius 13 Mycobacterium xenopi Streptococcus sanguinis Trichosporon asahii NOCARDIA Trichosporon inkin Trichosporon mucoides Nocardia abscessus Vibrio cholerae Nocardia asteroides Vibrio parahaemolyticus Nocardia brasiliensis Vibrio vulnificus Nocardia cyriacigeorgica Yersinia enterocolitica Nocardia farcinica Yersinia frederiksenii Nocardia nova 17 Yersinia intermedia Nocardia otitidiscaviarum Yersinia kristensenii Nocardia paucivorans Yersinia pseudotuberculosis 14 Nocardia pseudobrasiliensis Nocardia transvalensis MYCOBACTERIUM Nocardia veterana Nocardia wallacei Mycobacterium abscessus Mycobacterium avium MOULDS Mycobacterium chelonae Mycobacterium fortuitum group: 15 Acremonium sclerotigenum Mycobacterium alvei Alternaria alternata Mycobacterium farcinogenes Aspergillus brasiliensis Mycobacterium fortuitum Aspergillus flavus/oryzae Mycobacterium houstonense Aspergillus fumigatus Mycobacterium peregrinum Aspergillus lentulus Mycobacterium porcinum Aspergillus nidulans Mycobacterium senegalense
Load more

Recommended publications
  • Role of the Laboratory in TB Diagnosis and Management
    Role of the Laboratory in TB Diagnosis and Management Michael Pentella, Ph.D., D(ABMM), CIC Associate Director University Hygienic Lab Clinical Associate Professor, College of Public Health, University of Iowa Objectives • At the completion of this TB webinar, participants will: – Be familiar with the tests to diagnose latent tuberculosis and active tuberculosis – Recognize the tests available to detect Mycobacterium tuberculosis in clinical specimens – Understand the value of molecular tests to detect TB History of TB Diagnostics • Robert Koch announced in 1882 that he had found a microbe, Mycobacterium tuberculosis, that was the cause of "White Death", a disease responsible for one-seventh of all deaths in Europe in the late part of the 1800's. 1 Timeline of TB Infection Exposure 4-6 wks Latent Lifelong Adaptive Yrs-decades Containment T cell TB response (LTBI)* Active TB *Prevention efforts focus on detecting LTBI, most LTBI do not advance to active disease but those patients are at high risk particularly if they become immunocompromised. TB Infection vs. TB Disease TB in the body TB in the body Chest X-ray normal Chest X-ray abnormal Sputum not done Sputum smear and culture positive No symptoms Symptoms: cough, fever, weight loss Not infectious Infectious Not a case of TB Case of TB TB Algorithm • Collect sputum specimens at 3 different times and 8 hours apart (at least one must be a first morning specimen) for AFB smear and mycobacterial culture. • Perform MTD or NAAT test on the first smear positive sputum specimen 2 Diagnosis of
    [Show full text]
  • Species of Mycobacterium Tuberculosis Complex and Nontuberculous Mycobacteria in Respiratory Specimens from Serbia
    Arch. Biol. Sci., Belgrade, 66 (2), 553-561, 2014 DOI:10.2298/ABS1402553Z SPECIES OF MYCOBACTERIUM TUBERCULOSIS COMPLEX AND NONTUBERCULOUS MYCOBACTERIA IN RESPIRATORY SPECIMENS FROM SERBIA IRENA ŽIVANOVIĆ1, DRAGANA VUKOVIĆ1, IVANA DAKIĆ1 and BRANISLAVA SAVIĆ1 1 Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia Abstract - This study aimed to provide the first comprehensive report into the local pattern of mycobacterial isolation. We used the GenoType MTBC and CM/AS assays (Hain Lifescience) to perform speciation of 1 096 mycobacterial cultures isolated from respiratory specimens, one culture per patient, in Serbia over a 12-month period. The only species of the Mycobacterium tuberculosis complex (MTBC) identified in our study was M. tuberculosis, with an isolation rate of 88.8%. Ten different species of nontuberculous mycobacteria (NTM) were recognized, and the five most frequently isolated spe- cies were, in descending order, M. xenopi, M. peregrinum, M. gordonae, M. avium and M. chelonae. In total, NTM isolates accounted for 11.2% of all isolates of mycobacteria identified in pulmonary specimens. Our results suggest that routine differentiation among members of the MTBC is not necessary, while routine speciation of NTM is required. Key words: Mycobacterium tuberculosis, nontuberculous mycobacteria, identification, GenoType MTBC, GenoType CM/AS INTRODUCTION M. mungi in banded mongooses (Alexander et al., 2010), and M. orygis in animals of the Bovidae family Currently, the genus Mycobacterium encompasses (van Ingen et al., 2012) have recently been described. 163 species and 13 subspecies described in the list of Although all members of the complex are considered bacterial species with approved names (www.bacte- tubercle bacilli, the most important causative agent rio.cict.fr/m/mycobacterium.html).
    [Show full text]
  • Genome Sequencing of Mycobacterium Pinnipedii Strains
    Silva-Pereira et al. BMC Genomics (2019) 20:1030 https://doi.org/10.1186/s12864-019-6407-5 RESEARCH ARTICLE Open Access Genome sequencing of Mycobacterium pinnipedii strains: genetic characterization and evidence of superinfection in a South American sea lion (Otaria flavescens) Taiana T. Silva-Pereira1,2, Cássia Y. Ikuta2, Cristina K. Zimpel1,2, Naila C. S. Camargo1,2, Antônio F. de Souza Filho2, José S. Ferreira Neto2, Marcos B. Heinemann2 and Ana M. S. Guimarães1,2* Abstract Background: Mycobacterium pinnipedii, a member of the Mycobacterium tuberculosis Complex (MTBC), is capable of infecting several host species, including humans. Recently, ancient DNA from this organism was recovered from pre-Columbian mummies of Peru, sparking debate over the origin and frequency of tuberculosis in the Americas prior to European colonization. Results: We present the first comparative genomic study of this bacterial species, starting from the genome sequencing of two M. pinnipedii isolates (MP1 and MP2) obtained from different organs of a stranded South American sea lion. Our results indicate that MP1 and MP2 differ by 113 SNPs (single nucleotide polymorphisms) and 46 indels, constituting the first report of a mixed-strain infection in a sea lion. SNP annotation analyses indicate that genes of the VapBC family, a toxin-antitoxin system, and genes related to cell wall remodeling are under evolutionary pressure for protein sequence change in these strains. OrthoMCL analysis with seven modern isolates of M. pinnipedii shows that these strains have highly similar proteomes. Gene variations were only marginally associated with hypothetical proteins and PE/PPE (proline-glutamate and proline-proline-glutamate, respectively) gene families.
    [Show full text]
  • Zoonotic Tuberculosis in Mammals, Including Bovine and Caprine
    Zoonotic Importance Several closely related bacteria in the Mycobacterium tuberculosis complex Tuberculosis in cause tuberculosis in mammals. Each organism is adapted to one or more hosts, but can also cause disease in other species. The two agents usually found in domestic Mammals, animals are M. bovis, which causes bovine tuberculosis, and M. caprae, which is adapted to goats but also circulates in some cattle herds. Both cause economic losses including in livestock from deaths, disease, lost productivity and trade restrictions. They can also affect other animals including pets, zoo animals and free-living wildlife. M. bovis Bovine and is reported to cause serious issues in some wildlife, such as lions (Panthera leo) in Caprine Africa or endangered Iberian lynx (Lynx pardinus). Three organisms that circulate in wildlife, M. pinnipedii, M. orygis and M. microti, are found occasionally in livestock, Tuberculosis pets and people. In the past, M. bovis was an important cause of tuberculosis in humans worldwide. It was especially common in children who drank unpasteurized milk. The Infections caused by advent of pasteurization, followed by the establishment of control programs in cattle, Mycobacterium bovis, have made clinical cases uncommon in many countries. Nevertheless, this disease is M. caprae, M. pinnipedii, still a concern: it remains an important zoonosis in some impoverished nations, while wildlife reservoirs can prevent complete eradication in developed countries. M. M. orygis and M. microti caprae has also emerged as an issue in some areas. This organism is now responsible for a significant percentage of the human tuberculosis cases in some European countries where M. bovis has been controlled.
    [Show full text]
  • Mycobacteria and Disease in Southern Africa L
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Stellenbosch University SUNScholar Repository Transboundary and Emerging Diseases REVIEW ARTICLE Mycobacteria and Disease in Southern Africa L. Botha, N. C. Gey van Pittius and P. D. van Helden DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/Medical Research Council (MRC) Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa Keywords: Summary Mycobacterium tuberculosis complex; M. bovis; NTM; southern Africa The genus Mycobacterium consists of over 120 known species, some of which (e.g. M. bovis and M. tuberculosis) contribute extensively to the burden of infec- Correspondence: tious disease in humans and animals, whilst others are commonly found in the P. D. van Helden, DST/NRF Centre of environment but may rarely if ever be disease-causing. This paper reviews the Excellence for Biomedical Tuberculosis mycobacteria found in southern Africa, focussing on those in the M. tuberculosis Research/ Medical Research Council (MRC) complex as well as the non-tuberculous mycobacteria (NTM), identifying those Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human found in the area and including those causing disease in humans and animals, Genetics, Faculty of Health Sciences, and outlines some recent reports describing the distribution and prevalence of Stellenbosch University, PO Box 19063, the disease in Africa. Difficulties in diagnosis, host preference and reaction, Tygerberg 7505, South Africa. immunology and transmission are discussed. Tel.: +21 938 9124; Fax: +21 938 9863; E-mail: [email protected] Received for publication August 1, 2013 doi:10.1111/tbed.12159 slow-growing species (more than 7 days in culture) are Introduction mostly pathogenic (see Fig.
    [Show full text]
  • Mycobacteriology
    Mycobacteriology Margie Morgan, PhD, D(ABMM) Mycobacteria ◼ Acid Fast Bacilli (AFB) Kinyoun AFB stain Gram stain ❑ Thick outer cell wall made of complex mycolic acids (mycolates) and free lipids which contribute to the hardiness of the genus ❑ Acid Fast for once stained, AFB resist de-colorization with acid alcohol (HCl) ❑ AFB stain vs. modified or partial acid fast (PAF) stain ◼ AFB stain uses HCl to decolorize Mycobacteria (+) Nocardia (-) ◼ PAF stain uses H2SO4 to decolorize Mycobacteria (+) Nocardia (+) ◼ AFB stain poorly with Gram stain / beaded Gram positive rods ◼ Aerobic, no spores produced, and rarely branch Identification of the Mycobacteria ◼ For decades, identification started by determining the ability of a mycobacteria species to form yellow cartenoid pigment in the light or dark; followed by performing biochemical reactions, growth rate, and optimum temperature for growth. Obsolete ◼ With expanding taxonomy, biochemical reactions were unable to identify newly recognized species, so High Performance Liquid Chromatography (HPLC) became useful. Now also obsolete ◼ Current methods for identification: ❑ Genetic probes (DNA/RNA hybridization) ❑ MALDI-TOF Mass Spectrometry to analyze cellular proteins ❑ Sequencing 16 sRNA for genetic sequence information Mycobacteria Taxonomy currently >170 species ◼ Group 1 - TB complex organisms ❑ Mycobacterium tuberculosis ❑ M. bovis ◼ Bacillus Calmette-Guerin (BCG) strain ❑ Attenuated strain of M. bovis used for vaccination ❑ M. africanum ❑ Rare species of mycobacteria ◼ Mycobacterium microti ◼ Mycobacterium canetti ◼ Mycobacterium caprae ◼ Mycobacterium pinnipedii ◼ Mycobacterium suricattae ◼ Mycobacterium mungi ◼ Group 2 - Mycobacteria other than TB complex (“MOTT”) also known as the Non-Tuberculous Mycobacteria Disease causing Non-tuberculous mycobacteria (1) Slowly growing non tuberculosis mycobacteria ◼ M. avium-intracullare complex ◼ M. genavense ◼ M. haemophilum ◼ M. kansasii (3) Mycobacterium leprae ◼ M.
    [Show full text]
  • Non-Tuberculous Mycobacteria Isolated from New Zealand Soil Environments
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. Non-tuberculous Mycobacteria Isolated from New Zealand Soil Environments A thesis presented in partial fulfilment of the requirements for the degree of Masters of Philosophy in Microbiology at Massey University, Albany, New Zealand. Kasey Shirvington-Kime 2006 Abstract There is little information on the diversity of non-tuberculous mycobacteria (NTM) in New Zealand. This project has shown that diverse mycobacteria can be isolated from forest, pastoral and urban environments through the combined use of specialised decontamination techniques and selective media. Mycobacterium avium­ intracellulare complex (MAIC) was the most commonly isolated mycobacteria (40%) followed by M montefiorense/M triplex (20%). This is the first known isolation of M montefiorense/M triplex from soils in New Zealand. The greatest numbers of mycobacteria were isolated from peat-rich pastoral soils, followed by urban dust/organic matter and native forest soils. The majority of mycobacteria isolated were slow-growing. The greatest numbers of iso lates that were unable to be speciated further than Mycobacterium species using 16S rDNA sequencing (i.e. likely to be new species) were isolated from native forest soils. 11 Abstract ............................................................................ ii Table of Tables .................................................................v
    [Show full text]
  • The Impact of Chlorine and Chloramine on the Detection and Quantification of Legionella Pneumophila and Mycobacterium Spp
    The impact of chlorine and chloramine on the detection and quantification of Legionella pneumophila and Mycobacterium spp. Maura J. Donohue Ph.D. Office of Research and Development Center of Environmental Response and Emergency Response (CESER): Water Infrastructure Division (WID) Small Systems Webinar January 28, 2020 Disclaimer: The views expressed in this presentation are those of the author and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency. A Tale of Two Bacterium… Legionellaceae Mycobacteriaceae • Legionella (Genus) • Mycobacterium (Genus) • Gram negative bacteria • Nontuberculous Mycobacterium (NTM) (Gammaproteobacteria) • M. avium-intracellulare complex (MAC) • Flagella rod (2-20 µm) • Slow grower (3 to 10 days) • Gram positive bacteria • Majority of species will grow in free-living • Rod shape(1-10 µm) amoebae • Non-motile, spore-forming, aerobic • Aerobic, L-cysteine and iron salts are required • Rapid to Slow grower (1 week to 8 weeks) for in vitro growth, pH: 6.8 to 7, T: 25 to 43 °C • ~156 species • ~65 species • Some species capable of causing disease • Pathogenic or potentially pathogenic for human 3 NTM from Environmental Microorganism to Opportunistic Opponent Genus 156 Species Disease NTM =Nontuberculous Mycobacteria MAC = M. avium Complex Mycobacterium Mycobacterium duvalii Mycobacterium litorale Mycobacterium pulveris Clinically Relevant Species Mycobacterium abscessus Mycobacterium elephantis Mycobacterium llatzerense. Mycobacterium pyrenivorans, Mycobacterium africanum Mycobacterium europaeum Mycobacterium madagascariense Mycobacterium rhodesiae Mycobacterium agri Mycobacterium fallax Mycobacterium mageritense, Mycobacterium riyadhense Mycobacterium aichiense Mycobacterium farcinogenes Mycobacterium malmoense Mycobacterium rufum M. avium, M. intracellulare, Mycobacterium algericum Mycobacterium flavescens Mycobacterium mantenii Mycobacterium rutilum Mycobacterium alsense Mycobacterium florentinum. Mycobacterium marinum Mycobacterium salmoniphilum ( M. fortuitum, M.
    [Show full text]
  • Tuberculosis Caused by Mycobacterium Pinnipedii in a Wild South American Sea Lion Otaria Flavescens Stranded in Southern Brazil
    Vol. 133: 189–194, 2019 DISEASES OF AQUATIC ORGANISMS Published online March 28 https://doi.org/10.3354/dao03342 Dis Aquat Org NOTE Tuberculosis caused by Mycobacterium pinnipedii in a wild South American sea lion Otaria flavescens stranded in southern Brazil Aryse Martins Melo1,2,*, Rodolfo Pinho da Silva Filho3, Andrea von Groll4,5, Ana Júlia Reis4,5, Jaciara de Lourdes do Carmo Guimarães Diniz4,5, João Perdigão6, Isabel Portugal6, Pedro Eduardo Almeida da Silva4,5, Fabiane Borelli Grecco7, Melissa Orzechowski Xavier2,5 1Centro de Recuperação de Animais Marinhos, Universidade Federal do Rio Grande, Rio Grande, Rio Grande do Sul, 96200-580, Brazil 2Programa de Pós-Graduação em Parasitologia, Instituto de Biologia, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, 96160-000, Brazil 3Aiuká Consultoria em Soluções Ambientais, Avenida do Trabalhador, 1799, Praia Grande, São Paulo, 11720-000, Brazil 4Núcleo de Pesquisa em Microbiologia Médica, Faculdade de Medicina, Universidade Federal do Rio Grande, Rio Grande, Rio Grande do Sul, 96203-900, Brazil 5Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Medicina, Universidade Federal do Rio Grande, Rio Grande, Rio Grande do Sul, 96203-900, Brazil 6iMed.ULisboa, Instituto de Investigação do Medicamento, Faculdade de Farmácia, Universidade de Lisboa, Lisboa 1649-003, Portugal 7Faculdade de Veterinária, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, 96160-000, Brazil ABSTRACT: Tuberculosis (TB) in pinnipeds is typically caused by Mycobacterium pinnipedii, which has also been associated with infections in other species, such as cattle and humans. As a result, this pathogen has zoonotic potential and is a public health concern.
    [Show full text]
  • Complications in the Study of Ancient Tuberculosis: Presence of Environmental Bacteria in Human Archaeological Remains
    Journal of Archaeological Science 68 (2016) 5e11 Contents lists available at ScienceDirect Journal of Archaeological Science journal homepage: http://www.elsevier.com/locate/jas Complications in the study of ancient tuberculosis: Presence of environmental bacteria in human archaeological remains * Romy Müller a, Charlotte A. Roberts b, Terence A. Brown a, a Faculty of Life Sciences, Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester M1 7DN, UK b Department of Archaeology, Durham University, South Road, Durham DH1 3LE, UK article info abstract Article history: There are many reports of ancient DNA from bacteria of the Mycobacterium tuberculosis complex (MTBC) Received 16 October 2015 being present in skeletons with and without osteological indications of tuberculosis. A possible Received in revised form complication in these studies is that extracts might also contain DNA from the microbiome of the in- 22 February 2016 dividual whose remains are being analysed and/or from environmental bacteria that have colonised the Accepted 1 March 2016 skeleton after death. These contaminants might include ‘mycobacteria other than tuberculosis’ (MOTT), which are common in the environment, but which are not normally associated with clinical cases of tuberculosis. In this paper we show that MOTT of various types, as well as bacteria of related genera, are Keywords: Ancient DNA present in most if not all archaeological remains. Our results emphasise the complications inherent in the fi Authenticity of sequence data biomolecular study of archaeological human tuberculosis. The speci city of any polymerase chain re- Mycobacteria other than tuberculosis action directed at the MTBC cannot be assumed and, to confirm that an amplification is authentic, a Mycobacterium tuberculosis complex sequencing strategy must be applied that allows characterisation of the PCR product.
    [Show full text]
  • Mycobacterium Pinnipedii Tuberculosis in Native New Zealand Marine Mammals
    RESEARCH ARTICLE Pathology and molecular epidemiology of Mycobacterium pinnipedii tuberculosis in native New Zealand marine mammals 1 1¤a 1¤b 1 Wendi D. RoeID *, Baukje Lenting , Anna Kokosinska , Stuart Hunter , Padraig J. Duignan2, Brett Gartrell1, Lynn Rogers1, Desmond M. Collins3, Geoffrey W. de Lisle3, Kristene Gedye1, Marian Price-Carter3 1 School of Veterinary Science, Massey University, Palmerston North, New Zealand, 2 The Marine Mammal a1111111111 Centre, Sausalito, California, United States of America, 3 AgResearch, Palmerston North, New Zealand a1111111111 a1111111111 ¤a Current address: Wellington Zoo, Wellington, New Zealand a1111111111 ¤b Current address: College of Veterinary Medicine, University of Georgia, Athens, Georgia, United States of America a1111111111 * [email protected] Abstract OPEN ACCESS Mycobacterium pinnipedii causes tuberculosis in a number of pinniped species, and trans- Citation: Roe WD, Lenting B, Kokosinska A, Hunter mission to cattle and humans has been reported. The aims of this study were to: character- S, Duignan PJ, Gartrell B, et al. (2019) Pathology and molecular epidemiology of Mycobacterium ize the pathology and prevalence of tuberculosis in New Zealand marine mammals; use pinnipedii tuberculosis in native New Zealand molecular diagnostic methods to confirm and type the causal agent; and to explore relation- marine mammals. PLoS ONE 14(2): e0212363. ships between type and host characteristics. Tuberculosis was diagnosed in 30 pinnipeds https://doi.org/10.1371/journal.pone.0212363 and one cetacean. Most affected pinnipeds had involvement of the pulmonary system, sup- Editor: Stephen Raverty, Animal Health Centre, porting inhalation as the most common route of infection, although ingestion was a possible CANADA route in the cetacean.
    [Show full text]
  • Genome Sequencing of Mycobacterium
    Silva-Pereira et al. BMC Genomics (2019) 20:1030 https://doi.org/10.1186/s12864-019-6407-5 RESEARCH ARTICLE Open Access Genome sequencing of Mycobacterium pinnipedii strains: genetic characterization and evidence of superinfection in a South American sea lion (Otaria flavescens) Taiana T. Silva-Pereira1,2, Cássia Y. Ikuta2, Cristina K. Zimpel1,2, Naila C. S. Camargo1,2, Antônio F. de Souza Filho2, José S. Ferreira Neto2, Marcos B. Heinemann2 and Ana M. S. Guimarães1,2* Abstract Background: Mycobacterium pinnipedii, a member of the Mycobacterium tuberculosis Complex (MTBC), is capable of infecting several host species, including humans. Recently, ancient DNA from this organism was recovered from pre-Columbian mummies of Peru, sparking debate over the origin and frequency of tuberculosis in the Americas prior to European colonization. Results: We present the first comparative genomic study of this bacterial species, starting from the genome sequencing of two M. pinnipedii isolates (MP1 and MP2) obtained from different organs of a stranded South American sea lion. Our results indicate that MP1 and MP2 differ by 113 SNPs (single nucleotide polymorphisms) and 46 indels, constituting the first report of a mixed-strain infection in a sea lion. SNP annotation analyses indicate that genes of the VapBC family, a toxin-antitoxin system, and genes related to cell wall remodeling are under evolutionary pressure for protein sequence change in these strains. OrthoMCL analysis with seven modern isolates of M. pinnipedii shows that these strains have highly similar proteomes. Gene variations were only marginally associated with hypothetical proteins and PE/PPE (proline-glutamate and proline-proline-glutamate, respectively) gene families.
    [Show full text]